Merck & CompanyvsSanofi

MRK and SNY stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$137.78

Value $341B

-3.90%
MRK's page

Merck & Company (MRK) has a market value of $341B and Sanofi (SNY) $115B. Over the last year, with dividends, MRK moved +52.7% and SNY -3.9%. The P/E is 138.9 for MRK and 12.5 for SNY. Dividend yield: MRK 2.47%, SNY 4.88%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$341B

    SNY$115B

    MRK is 3.0 times SNY

  • Revenue, 12 months

    MRK$67.4B

    SNY$51.2B

    MRK is 1.3 times SNY

  • Net income, 12 months

    MRK$2.5B

    SNY$9.2B

    SNY is 3.7 times MRK

  • Operating margin

    MRK–

    SNY14.5%

  • ROIC

    MRK3.9%

    SNY5.8%

    1.9 points apart

  • P/E

    MRK138.9

    SNY12.5

    MRK is 11 times SNY

  • Dividend yield

    MRK2.5%

    SNY4.9%

    2.4 points apart

  • 5-year return

    MRK+94.3%

    SNY+14.4%

    79.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+94.3%

SNY+14.4%

10015020020222023202420252026
Returns by period
PeriodMRKWith dividendsSNYWith dividends
1 year since November 17, 2025+52.7%Price +48.4%-3.9%Price -9.0%
3 years since November 17, 2023+48.4%+14.1% a yearPrice +35.4%+15.1%+4.8% a yearPrice +0.2%
5 years since November 17, 2021+94.3%+14.2% a yearPrice +66.8%+14.4%+2.7% a yearPrice -7.6%
10 years since November 18, 2016+216.6%+12.2% a yearPrice +133.4%+77.2%+5.9% a yearPrice +17.7%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanySNYSanofi

Valuation

MRKSNY
Valuation
Price$137.78$47.12
Market value$341B$115B
Enterprise value (EV)$385B$125B
P/E138.912.5
P/E, 5-year median14.817.3
P/B7.61.4
EV/EBIT80.816.8
Free cash flow yield4.3%7.4%

Results and growth

MRKSNY
Results and growth
Revenue, 12 months$67.4B$51.2B
Net income, 12 months$2.5B$9.2B
Free cash flow, 12 months$14.7B$8.5B
Earnings per share, 12 months$0.98$3.74
Revenue growth, year on year1.3%6.2%
Revenue growth a year, past+9.4%over 5 years+3.9%over 5 years
EPS growth a year, past+21.2%over 5 years-8.2%over 5 years

Margins and returns on capital

MRKSNY
Margins and returns on capital
Gross margin71.8%77.2%
Operating margin–14.5%
Net margin3.6%17.9%
ROIC3.9%5.8%
ROE5.2%10.9%

Balance sheet

MRKSNY
Balance sheet
Cash$9.7B$9.0B
Total debt$53.8B$18.8B
Net debt / EBITDA5.7–
Interest cover2.4×–

Dividends and buybacks

MRKSNY
Dividends and buybacks
Dividend yield2.5%4.9%
Dividend per share, 12 months$3.40$2.30
Dividend growth a year, past+5.8%over 5 years+3.6%over 5 years
Buyback yield1.5%5.1%
Shareholder yield4.0%10.0%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or SNY

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or Sanofi?

By market value, Merck & Company ($341B) is about 3.0 times Sanofi ($115B), at today's prices.

How did MRK and SNY stock do over the last 10 years?

Since November 18, 2016, MRK's price moved +133.4% and SNY's +17.7%. With dividends: MRK +216.6% (+12.2% a year), SNY +77.2% (+5.9% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or SNY?

The dividend yield at today's price is 2.47% for Merck & Company and 4.88% for Sanofi. Over the last twelve months they paid $3.40 and $2.30 per share.

What is the P/E of MRK and SNY?

At today's price, the P/E is 138.9 for MRK and 12.5 for SNY. The median of the last five years was 14.8 and 17.3, which shows where each stands against its own past.

Which has the higher profit margins, Merck & Company or Sanofi?

Over the last twelve months, the net margin was 3.6% for Merck & Company and 17.9% for Sanofi, and the operating margin – and 14.5%. Revenue was $67.4B and $51.2B.

Which is the better investment, Merck & Company or Sanofi?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.